Cite
MLA Citation
Lihua E Budde et al.. “Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study.” Lancet oncology, vol. 23, no. 8, 2022, pp. 1055–1065. http://access.bl.uk/ark:/81055/vdc_100159752671.0x000020